IM Cannabis Corp.
IMCC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001792030
No open-market purchases or sales by IM Cannabis Corp. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $62.0K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding IM Cannabis Corp. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 33 | 34 | +1 |
| Shares | 4.91M | 9.15M | +4.24M (+86.3%) |
| Value | $16.4M | $19.4M | +$3.01M (+18.3%) |
New holders (5)
Institutions that held IM Cannabis Corp. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 1,174,874 | $2.51M | 0.01% |
| Two Sigma Securities, LLC | 15,872 | $34.0K | 0.00% |
| Citigroup Inc | 632 | $1.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 1 | $0 | 0.00% |
| Parallel Advisors, LLC | 44 | $0 | 0.00% |
Sold out (4)
Institutions that held IM Cannabis Corp. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Lynwood Capital Management Inc. | 275,000 | $907.0K |
| Two Sigma Investments, LP | 10,603 | $35.0K |
| Morgan Stanley | 486 | $2.00K |
| CoreCap Advisors, LLC | 22 | – |